Generics Industry News Search
 |
|
|
|
|
|
|
July 2011 News Archive |
|
|
| |
|
Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration for marketing 0.1% solution of Olopatadine hydrochloride eye drops...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Shire announced that it has filed lawsuits in the U.S. District Court for the District of New Jersey against each of Amneal Pharmaceuticals, and Sandoz, Inc. for infringement of certain of Shire's Vyvanese patents...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly, the drugmaker whose biggest-selling schizophrenia medicine Zyprexa survived a patent challenge in Britain two years ago, asked a U.K. judge to reject a parallel lawsuit by a closely held generics company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application filed with the US Food and Drug Administration for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly and Co., whose best-selling schizophrenia drug Zyprexa survived a United Kingdom court challenge by generic makers two years ago, lost a bid to dismiss another lawsuit over the medicine's patent in Britain...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug-maker Lupin on Wednesday said it has received approval from the US health regulator to market Amlodipine Benazepril capsules, used for the treatment of high blood pressure, in the American market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
An English judge has dealt a blow to AstraZeneca by overruling the patent rights of MedImmune, its subsidiary, to a screening technique used in drugs including Roches blockbuster eye treatment drug ranibizumab....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Irish pharmaceutical company Shire PLC is said on Thursday to have further sued two generic drugmakers to prevent approval of a new version of its attention deficit disorder drug Vyvanse...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories Ltd. announced the launching of Amlodipine Besylate and Benazepril Hydrochloride capsules in the strengths of 5mg/40mg and 10mg/40mg, a bio-equivalent generic version of Lotrel capsules in the US market on July 5th, following the approval by the US FDA of the company's ANDA for these products....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals Inc won an appeals court ruling that clears a hurdle in the companys effort to sell a generic version of Reckitt Benckiser Group Plc Mucinex cough medicine....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A US court will hear Tevas patent infringement case over generic Copaxone, and Englands High Court will hear Pfizers patent infringement case against Teva...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer Inc , the worlds largest drug maker, accused Apotex Inc in a lawsuit of infringing two U.S. patents for the nerve-pain drug Lyrica...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Bayers birth control franchise suffered a blow in Europe as patent regulators yanked protection on Yasmin
...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Gilead Sciences announced changes today of new licensing terms with four India-based drug manufacturers Hetero Drugs, Matrix Laboratories, Ranbaxy Laboratories and Strides Arcolab
...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Roche filed a lawsuit seeking to block generic-drug companies including Sandoz and Teva Pharmaceuticals from selling a low-cost version of the anti-nausea drug Aloxi...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Pharmaceuticals today said it's US subsidiary, Glenmark Generics, has received final approval from the FDA to market its generic Ursodiol tablets, used for treating cirrhosis, in the American market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories and Alchemia Limited, Brisbane, Australia announced today that Dr. Reddys has received final approval of Dr. Reddy's ANDA for Fondaparinux Sodium Injection, a bioequivalent generic version of Arixtra...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. and Amgen Inc. have reached a settlement agreement that would allow Teva to launch copycat versions of Neupogen and Neulasta, used to prevent infections in patients receiving chemotherapy, by November 2013 at the latest...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
India's most valuable drugmaker Sun Pharmaceutical Industries Ltd. expects generic medicine makers to find themselves in the same rough seas as innovator companies from 2015, as fewer new treatments hit the market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
US based drugstore chain Rite Aid Corporation has sued Ranbaxy Laboratories to recover litigation cost spent in lawsuits involving the Indian firm's generic drug metoclopramide
...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett today announced that it has received approval from the FDA for its ANDA of Diethylproprion HCl Tablets the therapeutic equivalent to the reference listed drug Tenuate...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharmaceuticals announced that USFDA has granted its subsidiary an approval for its ANDA to market a generic version of Uroxatral...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett today announced that it has received approval from the FDA for its Abbreviated New Drug Application of Phentermine HCl Capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced that it has begun shipping Oxymorphone Hydrochloride Extended-Release Tablets, CII 7.5mg and 15mg, a generic equivalent of Opana ER...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Egged on by the US Food and Drugs Administration's approval for its limited competition generic Arixtra (fondaparinux sodium), Dr Reddy's Laboratories is altering its generics strategy to focus more on complex molecules for all future launches...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries settled patent litigation related to its generic versions of Novartis AG Lotrel blood pressure drug...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Federal Circuit on Thursday ruled that Teva Women's Health Inc.'s decision to narrow the claims of a patent for the menopause drug (Cenestin) doomed its attempt to block Paddock Laboratories Inc. from making a generic version with a different coating...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Some of the weight was lifted from the shoulders of drug giant AstraZeneca this week when regulators approved its blood thinner Brilinta...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Prasco Laboratories, the Authorized Generics company, announced today it has signed a supply agreement with Shionogi Inc ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals Inc recently confirmed that it has filed an Abbreviated New Drug Application with the US Food and Drug Administration...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo Company today announced that it has closed the acquisition of Paddock Laboratories, a manufacturer of generic Rx pharmaceuticals and OTC specialty products for approximately $540 million in cash...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Onco Therapies Limited, a wholly owned subsidiary of Strides Arcolab Limited today announced that it has received US FDA approval for Gemcitabine for injection USP in 200mg, 1 gm and 2 gm dosage forms....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories announced today that it has launched Gemcitabine for Injection, a bioequivalent generic version of Gemzar in the US market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Bristol-Myers Squibb today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of Orencia for the treatment of adults with moderate to severe rheumatoid arthritis ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly announced that the U.S. Court of Appeals for the Federal Circuit has overturned a prior ruling by the U.S. District Court for the District of New Jersey and has upheld the validity of the company's method-of-use patent on Strattera...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Fujifilm and Dr Reddy's Laboratories have formed a joint venture to penetrate Japan's highly promising, but increasingly competitive, generic drug market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly & Co., the world's biggest maker of psychiatric drugs, won an appeals court ruling in its effort to block generic versions of attention deficit treatment Strattera
...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
